Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer: a multicenter real-life study (CAP29)

BACKGROUND: Pembrolizumab combined with chemotherapy is now first-line standard of care in advanced non-small cell lung cancer. This real-life study aimed to assess efficacy and safety of carboplatin-pemetrexed plus pembrolizumab in advanced non-squamous non-small cell lung cancer. METHODS: CAP29 is...

Descripción completa

Detalles Bibliográficos
Autores principales: Renaud, Emmanuelle, Ricordel, Charles, Corre, Romain, Leveiller, Guillaume, Gadby, Florence, Babey, Hélène, Annic, Josselin, Lucia, François, Bourbonne, Vincent, Robinet, Gilles, Descourt, Renaud, Orione, Charles, Quéré, Gilles, Geier, Margaux
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989798/
https://www.ncbi.nlm.nih.gov/pubmed/36895931
http://dx.doi.org/10.21037/tlcr-22-556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989798/
https://www.ncbi.nlm.nih.gov/pubmed/36895931
http://dx.doi.org/10.21037/tlcr-22-556

Ejemplares similares